THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 193,000 Value ($000) $179 Avg Close — Range —
Q1 2022
Shares 193,000 Value ($000) $183 Avg Close — Range —
Q4 2021
Shares 193,000 Value ($000) $177 Avg Close — Range —
Q3 2021
Shares 193,000 Value ($000) $172 Avg Close — Range —
Q2 2021
Shares 1,193,000 Value ($000) $1,075 Avg Close — Range —
Q1 2021
Shares 1,250,000 Value ($000) $1,223 Avg Close — Range —
Q4 2020
Shares 1,250,000 Value ($000) $1,180 Avg Close — Range —
Q3 2020
Shares 7,800,000 Value ($000) $7,058 Avg Close — Range —
Q2 2020
Shares 800,000 Value ($000) $768 Avg Close — Range —
Q1 2020
Shares 800,000 Value ($000) $770 Avg Close — Range —
Q4 2019
Shares 800,000 Value ($000) $803 Avg Close — Range —
Q3 2019
Shares 800,000 Value ($000) $728 Avg Close — Range —
Q2 2019
Shares 1,000,000 Value ($000) $865 Avg Close — Range —
Q1 2019
Shares 1,000,000 Value ($000) $985 Avg Close — Range —
Q4 2018
Shares 1,000,000 Value ($000) $1,044 Avg Close — Range —
Q3 2018
Shares 1,000,000 Value ($000) $1,188 Avg Close — Range —
Q2 2018
Shares 1,000,000 Value ($000) $985 Avg Close — Range —
Q1 2018
Shares 1,000,000 Value ($000) $1,017 Avg Close — Range —